Skip to main content

Table 6 Comparison between CHC and HCC regarding HOMA-IR index >4 and high risk variables

From: Chronic hepatitis c genotype-4 infection: role of insulin resistance in hepatocellular carcinoma

Variables CHC
HOMA-IR
>4
20(40%)
HCC
HOMA-IR
>4
26(52%)
Age   
> 57 years 13(65) 17(65)
Male gender: 14(70) 17 (65)
Obese(>25 kg/m 2 ) 16 (80) 17(65)
LFT (Mean ± SD)   
ALT (>37 IU/L) 18(90) 24(92)
AST (>40 IU/L) 18(90) 26(100)
T. Bil (> 1 mg/dL) 13(65) 26(100)
INR (> 1-) 18(90) 26(100)
GGT (>50 IU/L) 17(85) 26(100)
Biochemical tests   
Fasting glucose (>110 mg/dL) 20(100) 26(100)
Fasting insulin (>6IU/L) 20(100) 26(100)
HbA1c (>7%) 19(95) 25(96)
Cholesterol (> 200 mg/dL) 14(70) 15(58)
TG(> 150 mg/dL) 20(100) 25(96)
Tumor marker   
Serum AFP (>10 ng/mL) 20(100) 26(100)
HCV RNA (viral load) N(%)   
Moderate 12(60) 19(73)
High 7(35) 7(27)
Stage of Fibrosis   
III+IV 19(95) 26(100)